Navigation Links
Biolaxy Secures IND Approval for Oral Insulin
Date:11/24/2009

SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.

Diabetes is a disorder characteristic of high blood glucose and poor metabolism. The complications of diabetes often result in severe micro- and macro-vascular diseases, loss of vision, kidney failure, and amputation. Insulin, as an effective diabetic treatment, can slow down diabetic disease progression. However, insulin is given by multiple daily injections at present, which significantly hinders its use.

Oral drug administration is a preferred route. However, the gastrointestinal (GI) tract is designed to digest nutrients like proteins and presents significant challenges for oral insulin including enzyme degradation and poor absorption. Currently, there is no approved oral insulin product despite intensive research in this field.

Nodlin is developed with NOD technology, a patented bio-adhesive nano-particle oral delivery technology, to overcome the barriers of oral insulin.

"IND approval is a significant milestone achievement for Biolaxy," quoted from William Lee, CEO. "We have experienced long delay in the approval process due to regulatory uncertainties, but we are very happy now Biolaxy is back on track in full speed to develop urgently needed drugs for the patients."

    For more information, please contact:

     William Lee, Ph.D., CEO
     Phone: +86-21-6194-0758
     Email: info@biolaxy.com

    Press Contact
     Qianyu Zhao, Ph.D., Director of R&D
     Phone: +86-21-6194-0858 x807
     Email: '/>"/>
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related biology technology :

1. Osteotech Secures 10-Year Tissue Supply Agreement
2. Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
3. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
4. LS9 Secures $25 Million in Latest Round of Funding
5. Neurocrine Biosciences Secures Committed Equity Financing Facility
6. OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm
7. Cappella Inc. Secures $17.3 Million Series C Investment
8. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
9. Sinobiopharma Secures Rights to Seven Key Patents
10. Aerovance Secures $38 Million in Equity Financing
11. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 SynCardia Systems, ... and only FDA, Health Canada and CE (Europe) approved ... Centre in Scotland, which boasts more than 380,000 visitors ... Heart powered by the Freedom® portable driver as ... the most advanced exhibitions of its kind. , ...
(Date:5/23/2013)... 2013 Ralph Huber, President of PHI ... management products and emergency survival kits would be on ... made at the quarterly executive board meeting on May 22nd. ... silence for the Oklahoma tornado victims and used the opportunity ... their emergency kits is paramount. “When disaster strikes,” he ...
(Date:5/22/2013)... Cambridge Semantics was one of just ... Day” on Capitol Hill, hosted by The Data ... others to showcase how innovative data management applications can address ... (DATA Act). , Originally introduced in 2011 by Committee ... Mark Warner (D-VA ), the DATA Act is ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 ... of regenerative medicine, presented new data generated in collaboration ... (a leading health economics consultancy) demonstrating the significant healthcare ... and venous leg ulcers (VLU) place upon the US ... research, which reveal annual costs of up to $15 ...
Breaking Biology Technology:SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4
... Regenerative Medicine editorial board. , ... Vancouver, BC (PRWEB) ... announced today the appointment of its principle consultant, R. Lee Buckler, ... , , , ,Published by Future Medicine, Regenerative Medicine has become ...
... The inaugural year of The Kavli Prize will be ... Haakon Magnus presenting the prize to the seven Kavli laureates. ... will give lectures throughout the week. , , Note: The award ... be a press briefing at 11.15 AM (CET), September 9, ...
... Amylin,Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly ... today provided context and additional information,regarding the August 18, ... prior alert for BYETTA(R) (exenatide) injection referencing,pancreatitis. The companies ... as well as others, and previously reported these cases ...
Cached Biology Technology:Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board 2Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway) 2Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway) 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 2Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 4Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 5Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 6
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
(Date:5/22/2013)... technique that can detect molecular variants in chemical mixtures ... the most important, though time-consuming, processes in analytical chemistry. ... Nature , post-doctoral researcher David Patterson, Professor of Physics ... for Free-Electron Laser Science (CFEL) in Hamburg, Germany developed ... identify molecular variants apart, and to determine how much ...
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Detecting mirror molecules 2Detecting mirror molecules 3
... have been shown to adversely affect shell-forming creatures and corals, ... of Oceanography at UC San Diego has shown for the ... in fish. A brief paper published in the June ... in which fish that were exposed to high levels of ...
... the bustling economy of the cell, little bubbles called ... from the port - the cell membrane. Some of ... the cell,s protein factory. Scientists have long believed ... life-supporting nutrients and proteins through an independent process. By ...
... 2009 Scientists at Burnham Institute for Medical Research ... interfere with gene expression) reduce HIV replication and infectivity ... role in controlling the HIV life cycle. The study ... mechanism to help the virus hide from the immune ...
Cached Biology News:High carbon dioxide levels cause abnormally large fish ear bones 2Cells use import machinery to export their goods as well 2Cells use import machinery to export their goods as well 3MicroRNAs help control HIV life cycle 2
One-step, microplate or cuvet, colorimetric, detection range 0.1 mg/dL to 3 mg/dL. Procedure: 10 min....
... sizing single-stranded RNA ranging from 0.5 kb to 10 ... consists of nine bands in even increments (0.5 1 ... to simplify size estimation. The 1.5 kb band is ... and identification of RNA bands on the gel. All ...
... Serum • Mouse serum is collected off the clot ... weeks of age. Available Anticoagulants: N-02: ... K2EDTA N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
Rubeola (Measles) Antigen Preservative: No Preservatives...
Biology Products: